![George Scangos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 6 M $ in data 31/08/2026
George A. Scangos è un uomo d'affari che è stato a capo di 10 diverse aziende e attualmente occupa la posizione di presidente, amministratore delegato e direttore di Vir Biotechnology, Inc. È anche membro del Consiglio Nazionale dei Visitatori dell'Università della California e fa parte del consiglio di amministrazione di altre 5 aziende. Nella sua carriera passata George A. Scangos ha ricoperto la posizione di Direttore presso Decibel Therapeutics, Inc, Chief Executive Officer & Director presso Biogen, Inc. Amministratore Delegato presso Biogen Idec New Ventures, Inc. e Amministratore Delegato presso Biogen Idec, Inc. (North Carolina) (entrambe sono filiali di Biogen, Inc.), presidente, amministratore delegato e direttore di Exelixis, Inc., presidente di Bayer Biotechnology, presidente di Anadys Pharmaceuticals, Inc., presidente del California Healthcare Institute, vicepresidente senior di ricerca e sviluppo di Bayer, Inc., presidente della divisione biotecnologia di Bayer Corp., presidente di Pharmaceutical Research & Manufacturers of America e professore alla Johns Hopkins University. Ha ricevuto un dottorato dall'Università del Massachusetts e una laurea presso la Cornell University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/03/2026 | 41.750 ( 0,01% ) | 6 M $ | 31/08/2026 | |
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 09/05/2023 |
| AGILENT TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 01/01/2011 |
Octave Bioscience, Inc.
 Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Direttore/Membro del Consiglio | 12/07/2018 |
Biomedical Sciences Careers Program, Inc. | Direttore/Membro del Consiglio | - |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
UC Davis School of Medicine
 UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
IS Yatirim Menkul Degerler AS (Broker)
 IS Yatirim Menkul Degerler AS (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Life Science Cares, Inc. | Direttore/Membro del Consiglio | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| Società | Posizione | Fine |
|---|---|---|
| ░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 33 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
Taconic Biosciences GmbH
 Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Commercial Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer, Inc.
 Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Process Industries |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical drugs | Health Technology |
IS Yatirim Menkul Degerler AS (Broker)
IS Yatirim Menkul Degerler AS (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
Fondation Santé | |
UC Davis School of Medicine
UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baybio Institute | |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Bayer Biotechnology | |
Life Science Cares, Inc. | |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
